Genotoxicants target distinct molecular networks in neonatal neurons

Environmental Health Perspectives

Volumn 114, Issue 11, 2006, Pages 1703-1712

  Kisby, Glen E ^a   Olivas, Antoinette ^a   Standley, Melissa ^b   Lu, Xinfang ^b   Pattee, Patrick ^b   O'Malley, Jean ^b   Li, Xiaorong ^a   Muniz, Juan ^a   Nagalla, Srinavasa R ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Cerebellum; DNA damage; Granule cell; HN2; MAM; Methylazoxymethanol; Nitrogen mustard

Indexed keywords

CHLORMETHINE; METHYLAZOXYMETHANOL;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN FUNCTION; CELL CULTURE; CEREBELLUM; DNA DAMAGE; DNA MICROARRAY; DOWN REGULATION; ENVIRONMENTAL EXPOSURE; GENE EXPRESSION REGULATION; GENOTOXICITY; GRANULE CELL; IMMUNE RESPONSE; NERVE CELL DIFFERENTIATION; NEUROTOXICITY; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STRESS; UNINDEXED SEQUENCE;

ALKYLATING AGENTS; ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; CELL SURVIVAL; CELLS, CULTURED; CEREBELLUM; DNA DAMAGE; GENE EXPRESSION PROFILING; MECHLORETHAMINE; METHYLAZOXYMETHANOL ACETATE; MICE; MICE, INBRED C57BL; NEURONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 33750874719     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.9073     Document Type: Article

References (113)

1. Ahsgren I, Baldwin I, Goetzinger-Falk C, Erikson A, Flodmark O, Gillberg C. 2005. Ataxia, autism, and the cerebellum: a clinical study of 32 individuals with congenital ataxia. Dev Med Child Neurol 47:193-198.
2. Alam ZI, Jenner A, Daniel SE, Lees AJ, Cairns N, Marsden CD, et al. 1997. Oxidative DNA damage in the Parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J Neurochem 69:1196-1203.
3. Amin RP, Hamadeh HK, Bushel PR, Bennett L, Afshari CA, Paules RS. 2002. Genomic interrogation of mechanism(s) underlying cellular responses to toxicants. Toxicology 181-182:555-563.
4. Balduini W, Cimino M, Lombardelli G, Abbracchio MP, Peruzzi G, Cecchini T, et al. 1986. Microencephalic rats as a model for cognitive disorders. Clin Neuropharmacol 9:S8-S18.
5. Baraban SC, Schwartzkroin PA. 1996. Flurothyl seizure susceptibility in rats following prenatal methylazoxymethanol treatment. Epilepsy Res 23:189-194.
6. Bauman ML, Kemper TL. 2005. Neuroanatomic observations of the brain in autism: a review and future directions. Int J Dev Neurosci 23:183-187.
7. Becker AJ, Wiestler OD, Blumcke I. 2002. Functional genomics in experimental and human temporal lobe epilepsy: powerful new tools to identify molecular disease mechanisms of hippocampal damage. Prog Brain Res 135:161-173.
8. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B-Methodol 57:289-300.
9. Branum AM, Collman GW, Correa A, Keim SA, Kessel W, Kimmel CA, et al. 2003. The National Children's Study of environmental effects on child health and development. Environ Health Perspect 111:642-646.
10. 6-methylguanine from DNA of various mouse tissues following a single injection of N-methyl-nitrosourea. Chem Biol Interact 16:325-333.
11. Cattabeni F, Di Luca M. 1997. Developmental models of brain dysfunctions induced by targeted cellular ablations with methylazoxymethanol. Physiol Rev 77:199-215.
12. Cattaneo E, Reinach B, Caputi A, Cattabeni F, Di Luca M. 1995. Selective in vitro blockade of neuroepithelial cell proliferation by methylazoxymethanol, a molecule capable of inducing long lasting functional impairments. J Neurosci Res 41:640-647.
13. Chevassus-Au-Louis N, Jorquera I, Ben-Ari Y, Represa A. 1999. Abnormal connections in the malformed cortex of rats with prenatal treatment with methylazoxymethanol may support hyperexcitability. Dev Neurosci 21:385-392.
14. Children's Health Act. 2000. Public Law 106-310.
15. Colacitti C, Sancini G, DeBiasi S, Franceschetti S, Caputi A, Frassoni C, et al. 1999. Prenatal methylazoxymethanol treatment in rats produces brain abnormalities with morphological similarities to human developmental brain dysgeneses. J Neuropathol Exp Neurol 58:92-106.
16. Dabrowska MI, Becks LL, Lelli JL Jr, Levee MG, Hinshaw DB. 1996. Sulfur mustard induces apoptosis and necrosis in endothelial cells. Toxicol Appl Pharmacol 141:568-583.
17. Dacre JC, Goldman M. 1996. Toxicology and pharmacology of the chemical warfare agent sulfur mustard. Pharmacol Rev 48:289-326.
18. DeFeo MR, Mecarelli O, Ricci GF. 1995. Seizure susceptibility in immature rats with microencephaly induced by prenatal exposure to methylazoxymethanol acetate. Pharmacol Res 31:109-114.
19. Deschner EE, Ruperto J, Wong G, Newmark HL. 1991. Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia. Carcinogenesis 12:1193-1196.
20. Deschner EE, Ruperto JF, Wong GY, Newmark HL. 1993. The effect of dietary quercetin and rutin on AOM-induced acute colonic epithelial abnormalities in mice fed a high-fat diet. Nutr Cancer 20:199-204.
21. Deschner EE, Zedeck MS. 1986. Lipid peroxidation in liver and colon of methylazoxymethanol treated rats. Cancer Biochem Biophys 9:25-29.
22. Eizirik DL, Kisby GE. 1995. Cycad toxin-induced damage of rodent and human pancreatic β-islet cells. Biochem Pharmacol 50:355-365.
23. Eriksdotter-Nilsson M, Jonsson G, Dahl D, Björklund H. 1986. Astroglial development in microencephalic rat brain after fetal methylazoxymethanol treatment. Int J Dev Neurosci 4:353-362.
24. Esclaire F, Kisby GE, Milne J, Lesort M, Spencer P, Hugon J. 1999. The Guam cycad toxin methylazoxymethanol damages neuronal DNA and modulates tau mRNA expression and excitotoxicity. Exp Neurol 155:11-21.
25. Ferguson SA. 1996. Neuroanatomical and functional alterations resulting from early postnatal cerebellar insults in rodents. Pharmacol Biochem Behav 55:663-671.
26. Ferguson SA, Holson RR. 1997. Methylazoxymethanol-induced microencephaly in the brown Norway strain: behavior and brain weight. Int J Dev Neurosci 15:75-86.
27. Ferguson SA, Paule MG, Holson RR. 1996. Functional effects of methylzoxymethanol-induced cerebellar hypoplasia in rats. Neurotox Teratol 18:529-537.
28. Fiore M, Grace AA, Korf J, Stampachiacchiere B, Aloe L. 2004. Impaired brain development in the rat following prenatal exposure to methylazoxymethanol acetate at gestational day 17 and neurotrophin distribution. Neuroreport 15:1791-1795.
29. Flagstad P, Glenthoj BY, Didriksen M. 2005. Cognitive deficits caused by late gestational disruption of neurogenesis in rats: a preclinical model of schizophrenia. Neuropsychopharmacology 30:250-260.
30. Fonnum F, Lock EA. 2000. Cerebellum as a target for toxic substances. Toxicol Lett 113:9-16.
31. Frank D, Doenecke D, Albig W. 2003. Differential expression of human replacement and cell cycle dependent H3 histone genes. Gene 312:135-43.
32. Fujimori K, Inoue K, Nakazawa K, Maekawa A, Shibutani M, Takanaka A. 1992. Neurochemical and histological analysis of motor dysfunction observed in rats with methylnitrosourea-induced experimental cerebellar hypoplasia. Neurochem Res 17:223-231.
33. Gleeson JG. 2001. Neuronal migration disorders. Ment Retard Dev Disabil Res Rev 7:167-171.
34. Graef I, Karnofsky DA, Jager VB, Krichesky B, Smith HW. 1948. The clinical and pathologic effects of the nitrogen and sulfur mustards in laboratory animals. Am J Pathol 24:1-47.
35. Grenningloh G, Soehrman S, Bondallaz P, Ruchti E, Cadas H. 2004. Role of the microtubule destabilizing proteins SCG10 and stathmin in neuronal growth. J Neurobiol 58(1):60-69.
36. Guerrini R, Filippi T. 2005. Neuronal migration disorders, genetics, and epileptogenesis. J Child Neurol 20:287-299.
37. Hatten ME. 1999. Central nervous system neuronal migration. Annu Rev Neurosci 22:511-539.
38. Hatten ME. 2002. New directions in neuronal migration. Science 297:1660-1663.
39. Hoffman JR, Boyne LJ, Levitt P, Fischer I. 1996. Short exposure of methylazoxymethanol causes a long-term inhibition of axonal outgrowth from cultured embryonic rat hippocampal neurons. J Neurosci Res 46:349-359.
40. Hu T, Gibson DP, Carr GJ, Torontali SM, Tiesman JP, Chaney JG, et al. 2004. Identification of a gene expression profile that discriminates indirect-acting genotoxins from direct-acting genotoxins. Mutat Res 549:5-27.
41. Hur GH, Kim YB, Choi DS, Kim JH, Shin S. 1998. Apoptosis as a mechanism of 2-chloroethylethyl sulfide-induced cytotoxicity. Chem Biol Interact 110:57-70.
42. Ishigaki S, Niwa J, Ando Y, Yoshihara T, Sawada K, Doyu M, et al. 2002. Differentially expressed genes in sporadic amyotrophic lateral sclerosis spinal cords-screening by molecular indexing and subsequent cDNA microarray analysis. FEBS Lett 531:354-358.
43. Ishiguchi H, Izumi H, Torigoe T, Yoshida Y, Kubota H, Tsuji S, et al. 2004. ZNF143 activates gene expression in response to DNA damage and binds to cisplatin-modified DNA. Int J Cancer 111:900-909.
44. Jacobs KM, Kharazia VN, Prince DA. 1999. Mechanisms underlying epileptogenesis in cortical malformations. Epilepsy Res 36:165-188.
45. Jirakulsomchok S, Chronister RB, Yielding KL. 1982. Focal cerebellar dystrophy caused by transplacental administration of methylnitrosourea. Brain Res Bull 8:45-52.
46. Jones MZ. Gardner E. 1976. Pathogenesis of methylazoxymethanol-induced lesions in the postnatal mouse cerebellum. J Neuropathol Exp Neurol 35:413-444.
47. Kirby DM, Salemi R, Sugiana C, Ohtake A, Parry L, Bell KM, et al. 2004. NDUFS6 mutations are a novel cause of lethal neonatal mitochondrial complex I deficiency. J Clin Invest 114:837-845.
48. Kirmizis A, Bartley SM, Kuzmichev A, Margueron R, Reinberg D, Green R, et al 2004. Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27. Genes Dev 18:1592-1605.
49. Kisby GE, Kabel H, Hugon J, Spencer P. 1999. Damage and repair of nerve cell DNA in toxic stress. Drug Metab Rev 31:589-618.
50. Kisby GE, Lesselroth H, Olivas A, Samson L, Gold B, Tanaka K, et al. 2004. Role of nucleotide- and base-excision repair in genotoxin-induced neuronal cell death. DNA Repair 3:617-627.
51. Kisby GE, Springer N, Spencer PS. 2000. In vitro neurotoxic and DNA-damage properties of nitrogen mustard (HN2). J Appl Toxicol 20:S35-S41.
52. Kisby GE, Standley M, Lu X, O'Malley J, Lin B, Muniz J, et al. 2005. Molecular networks perturbed in a developmental animal model of brain injury. Neurobiol Dis 19:108-118.
53. 6-methylguanine in rat brain DNA. Nature 269:625-626.
54. Knecht K, Wiesmuller KH, Gnau V, Jung G, Meyermann R, Todd KG, et al. 2001. AMP deaminase in rat brain: localization in neurons and ependymal cells. J Neurosci Res 66:941-950.
55. Landrigan PJ, Kimmel CA, Correa A, Eskenazi B. 2004. Children's health and the environment: public health issues and challenges for risk assessment. Environ Health Perspect 112:257-265.
56. Loeffen J, van den Heuvel L, Smeets R, Triepels R, Sengers R, Trijbels F, et al. 1998. cDNA sequence and chromosomal localization of the remaining three human nuclear encoded iron sulphur protein (IP) subunits of complex I: the human IP fraction is completed. Biochem Biophys Res Commun 247:751-758.
57. Lu T, Pan Y, Kao SY, Li C, Kohane I, Chan J, et al. 2004. Gene regulation and DNA damage in the ageing human brain. Nature 429(6994):883-91.
58. Lyras L, Cairns NJ, Jenner A, Jenner P, Halliwell B. 1997. An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease. J Neurochem 68:2061-2069.
59. Mahnke DK, Sabina RL. 2005. Calcium activates erythrocyte AMP deaminase [isoform E (AMPD3)] through a protein-protein interaction between calmodulin and the N-terminal domain of the AMPD3 polypeptide. Biochemistry 44:5551-5559.
60. Mandel S, Grunblatt E, Maor G, Youdim MB. 2002. Early and late gene changes in MPTP mice model of Parkinson's disease employing cDNA microarray. Neurochem Res 27:1231-1243.
61. Matijasevic S, Boosalis M, Mackay W, Samson L, Ludlum D. 1993. Protection against chloroethylnitrosourea cytotoxicity by eukaryotic 3-methyladenine DNA glycosylase. Proc Natl Acad Sci USA 90:11855-11859.
62. Matsumoto H, Higa HH. 1966. Studies on methylazoxymethanol, the aglycone of cycasin: methylation of nucleic acids in vitro. Biochem J 98:20C-22C.
63. Matsumoto H, Spatz M, Laqueur GL. 1972. Quantitative changes with age in the DNA content of methylazoxymethanol-induced microencephalic rat brain. J Neurochem 19:297-306.
64. McDonald TP, Asano M. 1961. Effects of nitrogen mustard on the mouse brain. Am J Pathol 38:695-709.
65. McKittrick E, Gafken PR, Ahmad K, Henikoff S. 2004. Histone H3.3 is enriched in covalent modifications associated with active chromatin. Proc Natl Acad Sci USA 101:1525-1530.
66. Mecocci P, Beal MF, Cecchetti R, Polidori MC, Cherubini A, Chionne F, Avellini L, Romano G, Senin U. 1997. Mitochondrial membrane fluidity and oxidative damage to mitochondrial DNA in aged and AD human brain. Mol Chem Neuropathol 31:53-64.
67. Mecocci P, MacGarvey MS, Beal MF. 1994. Oxidative damage to mitochondrial DNA is increased in Alzheimer's Disease. Ann Neurol 36:747-751.
68. Mehl A, Rolseth V, Gordon S, Bjoraas M, Seeberg E, Fonnum F. 2000. Brain hypoplasia caused by exposure to trichlorfon and dichlorvos during development can be ascribed to DNA alkylation damage and inhibition of DNA alkyltransferase repair. Neurotoxicology 21:165-173.
69. Meier HL, Millard CB. 1998. Alterations in human lymphocyte DNA caused by sulfur mustard can be mitigated by selective inhibitors of poly(ADP-ribose) polymerase. Biochim Biophys Acta 1404:367-376.
70. Meira LB, Devaraj S, Kisby GE, Burns DK, Daniel RL, Hammer RE, et al. 2001. Heterozygosity for the mouse APEX gene results in phenotypes associated with oxidative stress. Cancer Res 61:5552-5557.
71. Mirnics K, Middleton FA, Marquez A, Lewis DA, Levitt P. 2000. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28:53-67.
72. Mody M, Cao Y, Cui Z, Tay KY, Shyong A, Shimizu E, et al. 2001. Genome-wide gene expression profiles of the developing mouse hippocampus. Proc Natl Acad Sci USA 98:8862-8867.
73. Motohashi H, Yamamoto M. 2004. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med 10:549-557.
74. Nagata Y, Matsumoto H. 1969. Studies on methylazoxymethanol: Methylation of nucleic acids in the fetal rat brain. Proc Soc Exp Biol Med 132:383-385.
75. Naik MU, Benedikz E, Hernandez I, Libien J, Hrabe J, Valsamis M, et al. 2000. Distribution of protein kinase M zeta and the complete protein kinase C isoform family in rat brain. J Comp Neurol 426(2):243-258.
76. Necchi D, Scherini E, Bernocchi G. 1997. Glial cell reaction to cis-dichlorodiammine platinum treatment in the immature rat cerebellum. Exp Neurol 144:219-226.
77. Neri M, Ugolini D, Bonassi S, Fucic A, Holland N, Knudsen LE, et al. 2006. Children's exposure to environmental pollutants and biomarkers of genetic damage II. Results of a comprehensive literature search and meta-analysis. Mutat Res 612:14-39.
78. Newton RK, Aardema M, Aubrecht J. 2004. The utility of DNA microarrays for characterizing genotoxicity. Environ Health Perspect 112:420-422.
79. Nishioka N, Arnold SE. 2004. Evidence for oxidative DNA damage in the hippocampus of elderly patients with chronic schizophrenia. Am J Geriatr Psychiatry 12:167-175.
80. Osborne MR, Wilman DEV, Lawley PD. 1995. Alkylation of DNA by the nitrogen mustard bis(2-chloroethyl) methylamine. Chem Res Toxicol 8:316-320.
81. Pasinetti GM. 2001. Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia. J Neurosci Res 65:471-476.
82. Pearson AG, Curtis MA, Waldvogel HJ, Faull RL, Dragunow M. 2005. Activating transcription factor 2 expression in the adult human brain: association with both neurodegeneration and neurogenesis. Neuroscience 133:437-451.
83. Poguet AL, Legrand C, Feng X, Yen PM, Meltzer P, Samarut J, et al. 2003. Microarray analysis of knockout mice identifies cyclin D2 as a possible mediator for the action of thyroid hormone during the postnatal development of the cerebellum. Dev Biol 254:188-199.
84. Povirk LF, Shuker DE. 1994. DNA damage and mutagenesis induced by nitrogen mustards. Mutat Res 318:205-226.
85. Ramanan N, Shen Y, Sarsfield S, Lemberger T, Schutz G, Linden DJ, et al. 2005. SRF mediates activity-induced gene expression and synaptic plasticity but not neuronal viability. Nat Neurosci 8:759-767.
86. Rinaldi T, Pick E, Gambadoro A, Zilli S, Maytal-Kivity V, Frontali L, et al. 2004. Participation of the proteasomal lid subunit Rpn11 in mitochondrial morphology and function is mapped to a distinct C-terminal domain. Biochem J 381:275-285.
87. Ronquist G, Rudolphi O, Engstrom I, Waldenstrom A. 2001. Familial phosphofructokinase deficiency is associated with a disturbed calcium homeostasis in erythrocytes. J Intern Med 249:85-95.
88. Ross ME, Walsh CA. 2001. Human brain malformations and their lessons for neuronal migration. Annu Rev Neurosci 24:1041-1070.
89. Scicchitano DA, Mellon I. 1997. Transcription and DNA damage: a link to a kink. Environ Health Perspect 105(suppl 1):145-153.
90. Scicchitano DA, Olesnicky EC, Dimitri A. 2004. Transcription and DNA adducts: what happens when the message gets cut off? DNA Repair 3:1537-1548.
91. Shiraki H, Yase Y. 1975. Amyotrophic lateral sclerosis in Japan. In: Handbook of Clinical Neurology (Vinken PJ, Bruyn GW, eds). Vol 22. System Disorders and Atrophy, Part 2. New York: American Elsevier, 353-419.
92. Singh S, Datta AN, Singh G. 1983. Retarded recovery of Purkinje cells in rats following cyclophosphamide treatment in early postnatal period. Indian J Exp Biol 21:539-545.
93. Slagsvold HH, Rosseland CM, Jacobs C, Khuong E, Kristoffersen N, Gaarder M, et al. 2003. High molecular weight DNA fragments are processed by caspase sensitive or caspase independent pathways in cultures of cerebellar granule neurons. Brain Res 984:111-121.
94. Smith SB, Brown CB, Wright ME, Yielding KL. 1987. Late-onset cerebellar degeneration in mice induced transplacentally by methylnitrosourea. Teratog Carcinog Mutagen 7:449-463.
95. Somani SM, Babu SR. 1989. Toxicodynamics of sulfur mustard. Int J Clin Pharmacol Ther Toxicol 27:419-435.
96. Spencer PS, Daniels JL, Kisby GE. 1999. Mustard Warfare Agents and Related Substances, in Experimental and Chemical Neurotoxicology, 2nd ed (Spencer PS, Schaumburg HH, eds). New York:Oxford University Press.
97. Spencer PS, Kisby GE, Ludolph AC. 1991. Slow toxins, biologic markers, and long-latency neurodegenerative disease in the western Pacific region. Neurology 41:62-66.
98. Sullivan KM, Storb R, Shulman HM, Shaw CM, Spence A, Beckham C, et al. 1982. Immediate and delayed neurotoxicity after mechlorethamine preparation for bone marrow transplantation. Ann Int Med 97:182-189.
99. Sullivan-Jones P, Gouch AB, Holson RR. 1994. Postnatal methylazoxymethanol: sensitive periods and regional selectivity of effects. Neurotoxicol Teratol 16:631-637.
100. Sun J, Wang YX, Sun MJ. 1999. Apoptosis and necrosis induced by sulfur mustard in Hela cells. Acta Pharmacol Sin 20:445-448.
101. Talamini LM, Koch T, Luiten PG, Koolhaas JM, Korf J. 1999. Interruptions of early cortical development affect limbic association areas and social behaviour in rats; possible relevance for neurodevelopmental disorders. Brain Res 847:105-120.
102. Talamini LM, Koch T, Ter Horst GJ, Korf J. 1998. Methylazoxymethanol acetate-induced abnormalities in the entorhinal cortex of the rat; parallels with morphological findings in schizophrenia. Brain Res 789:293-306.
103. Tokuda K, Bodell WJ. 1987. Cytotoxicity and sister chromatid exchanges in 9L cells treated with monofunctional and bifunctional nitrogen mustards. Carcinogenesis 8:1697-1701.
104. Tomoda T, Kim JH, Zhan C, Hatten ME. 2004. Role of Unc51.1 and its binding partners in CNS axon outgrowth. Genes Dev 18:541-558.
105. Vadigepalli R, Chakravarthula P, Zak DE, Schwaber JS, Gonye GE. 2003. PAINT: a promoter analysis and interaction network generation tool for gene regulatory network identification. OMICS 7:235-252.
106. Vorhees CV, Fernandez K, Dumas RM, Haddad RK. 1984. Pervasive hyperactivity and long-term learning impairments in rats with induced microencephaly from prenatal exposure to methylazoxymethanol. Dev Brain Res 15:1-10.
107. Wallace CS, Reitzenstein J, Withers GS. 2003. Diminished experience-dependent neuroanatomical plasticity: evidence for an improved biomarker of subtle neurotoxic damage to the developing rat brain. Environ Health Perspect 111:1294-1298.
108. Wick A, Wick W, Hirrlinger J, Gerhardt E, Dringen R, Dichgans J, et al. 2004. Chemotherapy-induced cell death in primary cerebellar granule neurons but not in astrocytes: in vitro paradigm of differential neurotoxicity. J Neurochem 91:1067-1074.
109. Wijen JP, Nivard MJ, Vogel EW. 2000. The in vivo genetic activity profile of the monofunctional nitrogen mustard 2-chloroethylamine differs drastically from its bifunctional counterpart mechlorethamine. Carcinogenesis 21:1859-1867.
110. Witke W. 2004. The role of profilin complexes in cell motility and other cellular processes. Trends Cell Biol 14:461-469.
111. Yamasaki T, Kawaji K, Ono K, Bito H, Hirano T, Osumi N, et al. 2001. Pax6 regulates granule cell polarization during parallel fiber formation in the developing cerebellum. Development 128:3133-3144.
112. Yarmola EG, Bubb MR. 2006. Profilin: emerging concepts and lingering misconceptions. Trends Biochem Sci 31(4):197-205.
113. Zhang ZX, Anderson DW, Mantel N, Román GC. 1996. Motor neuron disease on Guam: geographic and familial occurrence, 1956-85. Acta Neurol Scand 94:51-59.